drugset / Trial / NCT04392778
Clinical Use of Stem Cells for the Treatment of Covid-19
Phase 1/2
Completed
30 enrolled
SBÜ Dr. Sadi Konuk Eğitim ve Araştırma Hastanesi
Istinye University · collabLiv Hospital (Ulus) · collabRegenerative Medicine and Stem Cell Production Center Liv MedCell · collab
RandomizedParallel-groupQuadruple-blindTreatment
Summary
This study aims to use the regenerative and repair abilities of stem cells to fight against the harmful effects of the novel coronavirus Covid-19 and therefore develop a treatment strategy. It is known that fatalities from this virus is largely caused by its damage to lungs and other organs. As the disease progresses, these organs fail and lead to mortality. Our hope is that the stem cell transplantation from healthy donors will repair the damage caused by the virus and result in a healthy recovery.
Timeline
- Start
- 2020-04-01
- Primary completion
- 2020-11-01
- Completion
- 2020-11-30
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | mesenchymal stem cells | Cell therapy | 3 cells/kg | Intravenous |